Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Holders of 5% or more of FNCH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Finch Therapeutics Group, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Finch Therapeutics Group, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Finch Therapeutics Group, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 13, 2023 | Ugwumba Chidozie | 13GOld format | – | – | – | SEC |
| Feb 14, 2022 | Walton Thomas Layton | 13GOld format | – | – | – | SEC |
| Feb 14, 2022 | Ugwumba Chidozie | 13GOld format | – | New | – | SEC |
| Apr 1, 2021 | Crestovo Investor LLC | 13DOld format | – | New | – | SEC |
| Mar 29, 2021 | Haft Nicholas | 13DOld format | – | New | – | SEC |
| Mar 26, 2021 | Walton Thomas Layton | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Finch Therapeutics Group, Inc. shares.
No Form 144 notices for Finch Therapeutics Group, Inc. are on file.